The gold market faced significant developments throughout 2025 as participants responded to evolving drivers, including US ...

S&P 500 gained 17.6% in 2025 led by Tech & AI tailwinds. Click for my full review of the changes made to my holdings and what ...

China's commerce ministry is reviewing Meta's (META) $2 billion acquisition of AI startup Manus for potential violations of ...

Inovio’s upside hinges on INO-3107 for HPV-6/11 RRP with FDA PDUFA Oct 2026, regulatory risk, tight cash, and cheap EV. Check ...

Amazon.com, Inc. stock lagged in 2025, but strong EPS growth and low valuation suggest upside. Click for more on AMZN stock ...

Centerspace (CSR) upgraded to Buy: strong NOI growth, high occupancy, 4.63% dividend, buybacks, and strategic review upside.

CGUS ETF review vs SPY: performance, volatility and valuation risks (29x P/E). See here to know whether it is a smart core ...

Global markets endured a volatile run in 2025, but when the last trades closed on Dec. 31, all the major asset classes posted ...

Series D & J—with strong dividend coverage and moderate redemption risk. Read my analysis of SCHW and its preferreds.

Discover how the AFC Asia Frontier Fund hit record NAV in 2025 with +17.5% returns. Learn about its low valuations and ...

The Kroger Co. ( KR) announced on Friday that it sold its Vitacost subsidiary to iHerb for an undisclosed amount. The ...

Axsome Therapeutics (AXSM) stock gains as the FDA grants priority review to expand its depression drug Auvelity for Alzheimer ...